TGFβ1 antagonistic peptides inhibit TGFβ1-dependent angiogenesis

Biochemical Pharmacology

Volumn 77, Issue 5, 2009, Pages 813-825

  Serratì, Simona ^a   Margheri, Francesca ^a   Pucci, Marco ^a   Cantelmo, Anna Rita ^b   Cammarota, Rosaria ^b   Dotor, Javier ^c   Borràs Cuesta, Francisco ^c   Fibbi, Gabriella ^a   Albini, Adriana ^b   Del Rosso, Mario ^a  

^a Center for the Study at Molecular and Clinical Level of Chronic   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Angiogenesis; PAI 1; SMAD; TGF ; uPAR

Indexed keywords

FOCAL ADHESION KINASE; INHIBITOR PROTEIN; LYSYLARGINYLISOLEUCYLTRYPTOPHYLPHENYLALANYLISOLEUCYLPROLYLARGINYLSERYLSERYLTRYPTOPHYLTYROSYLGLUTAMYLARGINYLALANINE; MATRIGEL; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD2 PROTEIN; SMAD3 PROTEIN; THREONYLSERYLLEUCYLASPARTYLALANYLSERYLISOLEUCYLISOLEUCYLTRYPTOPHYLALANYLMETHIONYLMETHIONYLGLUTAMINYLASPARAGINE; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; PEPTIDE; PRIMER DNA; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE SEQUENCE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MORPHOGENESIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR PROMOTION; UPREGULATION; WESTERN BLOTTING; CAPILLARY; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

BASE SEQUENCE; BLOTTING, WESTERN; CAPILLARIES; CELL PROLIFERATION; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 59949099664     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.10.036     Document Type: Article

References (53)

1. Seoane J. The TGFbeta pathway as a therapeutic target in cancer. Clin Transl Oncol 10 (2008) 14-19
2. Pardali K., and Moustakas A. Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochem Biophys Acta 1775 (2007) 21-62
3. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci U S A 100 (2003) 8621-8623
4. Vicent S., Luis-Ravelo D., Anton I., Garcia-Tunon I., Borras-Cuesta F., Dotor J., et al. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res 68 (2008) 2275-2285
5. Enholm B., Paavonen K., Ristimaki A., Kumar V., Gunji Y., Kleftstrom J., et al. Comparison of VEGF, VEGF-B, VEGF-C and Sng-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14 (1997) 2475-2483
6. Benckert C., Jonas S., Cramer C., Von Marschall Z., Schafer G., Peters M., et al. Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63 (2003) 1083-1092
7. Pollman M.J., Naumovski L., and Gibbons G.H. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99 (1999) 2019-2026
8. Saksela O., Moscatelli D., and Rifkin D.B. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105 (1987) 957-963
9. Ferrari G., Pintucci G., Seghezzi G., Hyman K., Galloway A.C., and Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci U S A 103 (2006) 17260-17265
10. Goumans M.J., Lebrin F., and Valdimarsdottir G. Controlling the angiogenic switch. A balance between two distinct TGF-beta receptor signalling pathways. TMC 13 (2003) 301-307
11. Lebrin F., Deckers M., Bertolino P., and Ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc Res 65 (2005) 599-608
12. Baramova E.N., Bajou K., Remacle A., L'Hoir C., Krell H.W., Weidle U.H., et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405 (1997) 157-162
13. Distler O., Neidhart M., Gay R.E., and Gay S. The molecular control of angiogenesis. Int Rev Immunol 21 (2002) 33-49
14. Odekon L.E., Sato Y., and Rifkin D.B. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150 (1992) 258-263
15. Flaumenhaft R., Abe M., Mignatti P., and Rifkin D.B. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol 118 (1992) 901-909
16. Odekon L.E., Blasi F., and Rifkin D.B. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J Cell Physiol 158 (1994) 398-407
17. Matrisian L.M., and Hogan B.L. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 24 (1990) 219-259
18. Fibbi G., Pucci M., D'Alessio S., Grappone C., Pellegrini G., Salzano R., et al. Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system. Growth Factors 19 (2001) 87-100
19. Mignatti P., Mazzieri R., and Rifkin D.B. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 113 (1991) 1193-1201
20. Mandriota S.J., Seghezzi G., Vassalli J.D., Ferrara N., Mazzieri R., Mignatti P., et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 270 (1995) 9709-9716
21. Ezquerro I.J., Lasarte J.J., Dotor J., Castilla-Cortazar I., Bustos M., Penuelas I., et al. A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 22 (2003) 12-20
22. Dotor J., López-Vázquez A.B., Lasarte J.J., Sarobe P., Garcia-Granero M., Riezu-Boj J.I., et al. Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library. Cytokine 39 (2007) 106-115
23. Santiago B., Gutierrez-Canas I., Dotor J., Palao G., Lasarte J.J., Ruiz J., et al. Topical application of a TGF-β1 receptor III derived TGF-β1 antagonistic peptide ameliorates bleomycin induced skin fibrosis. J Invest Dermatol 125 (2005) 450-455
24. D'Alessio S., Fibbi G., Cinelli M., Guiducci S., Del Rosso A., Margheri F., et al. MMP-12-dependent cleavage of urokinase receptor in Systemic Sclerosis endothelial cell results in impaired angiogenesis. Arthritis Rheum 50 (2004) 3275-3285
25. Fibbi G., Pucci M., Grappone C., Pellegrini G., Salzano R., Casini A., et al. Function of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor. Hepathology 29 (1999) 868-878
26. Sankar S., Mahooti-Brooks N., Bansen L., McCarthy T.L., Centrella M., and Madri J.A. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97 (1996) 1436-1446
27. Bein K., Odell-Fiddler E.T., and Drinane M. Role of TGF-beta1 and JNK signaling in capillary tube patterning. Am J Physiol Cell Physiol 287 (2004) 1012-1022
28. Kleinman H.K., and Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15 (2005) 378-386
29. Leask A. Scar wars: is TGFβ the phantom menace in scleroderma?. Arthritis Res Ther 8 (2006) 213
30. Massagué J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev 19 (2005) 2783-2810
31. Qing J., Zhang Y., and Derynck R. Structural and functional characterization of the transforming growth factor-beta-induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem 275 (2000) 38802-38812
32. Yu L., Hebert M.C., and Zhang Y.E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21 (2002) 3749-3759
33. Goldberg P.L., MacNaughton D.E., Clements R.T., Minnear F.L., and Vincent P.A. p38 MAPK activation by TGF-β1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol Physiol 282 (2002) L146-L154
34. Woodward R.N., Finn A.V., and Dichek D.A. Identification of intracellular pathways through which TGF-beta1 upregulates PAI-1 expression in endothelial cells. Atherosclerosis 186 (2006) 92-100
35. Lu Q., Harrington E.O., Jackson H., Morin N., Shannon C., and Rounds S. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation. J Appl Physiol 101 (2006) 375-384
36. Ishida A., Fujita N., Kitazawa R., and Tsuruo T. Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone. J Biol Chem 277 July (29) (2002) 26217-26224
37. Chen Y.Q., Sloan-Lancaster J., Berg D.T., Richardson M.A., Grinnell B., and Tseng-Crank J. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells. Thromb Haemost 86 (2001) 1563-1572
38. Walsh M.F., Ampasala D.R., Hatfield J., Vander Heide R., Suer S., Rishi A.K., et al. Transforming growth factor-β stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am J Pathol 173 (2008) 385-399
39. Kovacic-Milivojevié B., Roediger F., Almeida E.A., Damsky C.H., Gardner D.G., and Ilic D. Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell 12 (2001) 2290-2307
40. Korah R., Choi L., Barrios J., and Wieder R. Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 88 (2004) 17-28
41. Hakim Z.S., Di Michele L.A., Doherty J.T., Homeister J.W., Beggs H.E., Reichardt L.F., et al. Conditional deletion of focal adhesion kinase leads to defects in ventricular septation and outflow tract alignment. Mol Cell Biol 27 (2007) 5352-5364
42. Govindarajan G., Eble D.M., Lucchesi P.A., and Samarel A.M. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circ Res 87 (2000) 710-716
43. Braren R., Hu H., Kim Y.H., Beggs H.E., Reichardt L.F., and Wang R. Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 172 (2006) 151-162
44. Peng X., Ueda H., Zhou H., Stokol T., Shen T.L., Alcaraz A., et al. Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovasc Res 64 (2004) 421-430
45. Jakowlew S.B. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev 25 (2006) 435-457
46. Tuxhorm J.A., McAlhani S.J., Yang F., Dang T.D., and Rowley D.R. Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 62 (2002) 6021-6025
47. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappel s, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 301 (2004) 775-777
48. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor β in fibroblastic and epithelial cells. J Biol Chem 269 (1994) 6271-6274
49. Nakagawa T., Li J.H., Garcia G., Mu W., Piek E., Bottinger E.P., et al. TGF-beta induces proangiogenic factors via parallel but distinct Smad pathways. Kidney Int 66 (2004) 862-863
50. Akhurst R.J. TGF-beta antagonists: why suppress a tumor suppressor?. J Clin Invest 109 (2002) 1533-1536
51. de Caestecker M.P., Piek E., and Robert A.B. Role of transforming growth factor-beta signalling in cancer. J Natl Cancer Inst 92 (2000) 1388-1402
52. Wakefield L.M., Piek E., and Bottinger E.P. TGF-beta signalling in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 6 (2001) 67-82
53. Sporn M.B. The early history of TGFβ, and a brief glimpse of its future. Cytokine Growth Factor Rev 17 (2006) 3-7